I’m as hopeful as all the CYDY investors that BT
Post# of 145467
![Avatar](/images/ProfileImages/573000060_60093_FD245EF6-37BD-4C88-9356-29519D0376AD.jpeg)
I don’t remember if it was this board or another, but I recall a discussion regarding BTD filing and companies talking to the FDA about the packet prior to the application. Obviously the key opinion leaders in CYDY, including a couple of distinguished doctors in the cancer field, agreed with NP that BTD for cancer should be filed, even with only data from 2 patients. But based on information I’ve read before, it’s possible CYDY has exchanged emails or had a discussion with the FDA about their data and the BTD application.
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)